Prevalence and Determinants of Impaired Bone Mineral Density and Fractures in the First National Dutch Wilms Tumor Survivor Cohort, a National DCCSS ‐ LATER Study
Cancer Medicine · 2025
DOI: 10.1002/cam4.71229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Francis S P L Wens und 21 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Wilms Tumor, Bone Density, Fractures, Bone, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Kinderen Kankervrij, Maarten van der Weijden Foundation.
Abstract (Originalsprache)
Background
Wilms tumors (WT) are the most common kidney tumors in children, with excellent survival rates (90%). However, late adverse effects warrant attention. Limited data exist on musculoskeletal sequelae in WT survivors. We aimed to assess the prevalence and determinants of impaired bone mineral density (BMD) and fractures in a national cohort of Dutch WT survivors.
Method
This cross‐sectional study includes WT survivors treated between 1963 and 2002, recruited as part of the DCCSS‐LATER cohort between 2016 and 2020. Dual‐energy X‐ray absorptiometry (DXA) scans were used to assess BMD. Low BMD was defined as a Z ‐score ≤ 1. From 5 years after diagnosis, fracture prevalence was assessed by questionnaires. Univariable logistic regression was used to analyze associations between impaired BMD as well as fractures with independent variables like patient characteristics, treatments, comorbidities, and lifestyle‐related factors.
Results
Of 437 invited kidney tumor survivors, 233 WT survivors participated (median age 32.1 years, median follow‐up 27.8 years). DXA scans and fracture data were available for 173 and 221 WT survivors, respectively. Low BMD at any site was observed in 26% ( n = 46/173) of survivors and was significantly associated with treatment including ≥ 4 drugs (OR 2.76; 95% CI = 1.13–6.70). Abdominal radiotherapy doses > 30 Gy (OR 4.84; 95% CI = 1.06–22.2) were significantly associated with low lumbar spine BMD. The prevalence of fragility fractures was 16.3% ( n = 36/221). The standardized incidence ratio (SIR) of any first fracture was 2.34 for males and 5.38 for females.
Conclusion
Wilms tumor survivors treated with ≥ 4 drugs or abdominal radiotherapy (> 30 Gy) seem to be at increased risk of impaired BMD; this could indicate the need for surveillance for this subset of Wilms tumor survivors exposed to these treatment regimens in the past.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- University Medical Center Utrecht, Utrecht, the Netherlands.
- University of Amsterdam, Amsterdam, the Netherlands.
- Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, the Netherlands.
- Radboud University Medical Center, Nijmegen, the Netherlands.
- Amsterdam University Medical Center, Amsterdam, the Netherlands.
ORCID-Profile: Francis S P L Wens, Jenneke E van Atteveld
Förderung
- Stichting Kinderen Kankervrij
- Maarten van der Weijden Foundation
Zitieren
APA
Wens, F. S. P. L., de Winter, D. T. C., Janssens, G. O., Litjens, R., van Atteveld, J. E., Nievelstein, R. A. J., Hobbelink, M. G. G., de Vries, A. C. H., Loonen, J. J., van Dulmen-den Broeder, E., van der Pal, H. J. H., Pluijm, S. M. F., Kremer, L. C. M., van der Heiden-van der Loo, M., Louwerens, M., van Santen, H. M., Olsson, D. S., Hoefer, I., van den Berg, S. A. A., …, & van den Heuvel-Eibrink, M. M. (2025). Prevalence and Determinants of Impaired Bone Mineral Density and Fractures in the First National Dutch Wilms Tumor Survivor Cohort, a National DCCSS ‐ LATER Study. Cancer Medicine. https://doi.org/10.1002/cam4.71229
Vancouver
Wens FSPL, de Winter DTC, Janssens GO, Litjens R, van Atteveld JE, Nievelstein RAJ, et al. Prevalence and Determinants of Impaired Bone Mineral Density and Fractures in the First National Dutch Wilms Tumor Survivor Cohort, a National DCCSS ‐ LATER Study. Cancer Medicine. 2025. doi:10.1002/cam4.71229
BibTeX
@article{Wens2025,
author = {Wens, Francis S P L and de Winter, Demi T C and Janssens, Geert O and Litjens, Rens and van Atteveld, Jenneke E and Nievelstein, Rutger A J and Hobbelink, Monique G G and de Vries, Andrica C H and Loonen, Jacqueline J and van Dulmen-den Broeder, Eline and van der Pal, Helena J H and Pluijm, Saskia M F and Kremer, Leontien C M and van der Heiden-van der Loo, Margriet and Louwerens, Marloes and van Santen, Hanneke M and Olsson, Daniel S and Hoefer, Imo and van den Berg, Sjoerd A A and van Tinteren, Harm and Neggers, Sebastian J C M M and van den Heuvel-Eibrink, Marry M},
title = {Prevalence and Determinants of Impaired Bone Mineral Density and Fractures in the First National Dutch Wilms Tumor Survivor Cohort, a National DCCSS ‐ LATER Study},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71229}
}
EUVIMED